Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients
2012 ◽
Vol 3
(6)
◽
pp. 1314-1318
◽
HYUN JUNG KIM
◽
JINA YUN
◽
HAN JO KIM
◽
KYOUNG HA KIM
◽
SE HYUNG KIM
◽
...
2012 ◽
Vol 69
(6)
◽
pp. 1641-1645
◽
Alberto Zaniboni
◽
Enrico Aitini
◽
Sandro Barni
◽
Daris Ferrari
◽
Stefano Cascinu
◽
...
2015 ◽
Vol 51
◽
pp. S432
◽
B. Kim
◽
K.W. Lee
◽
M.J. Kim
◽
H.S. Han
◽
Y.L. Park
◽
...
2018 ◽
Vol 96
(1)
◽
pp. 1-7
Takuya Ishikawa
◽
Hiroki Kawashima
◽
Eizaburo Ohno
◽
Hiroshi Matsubara
◽
Yoji Sasaki
◽
...
2017 ◽
Vol 49
(3)
◽
pp. 706-716
◽
Keun-Wook Lee
◽
Bum Jun Kim
◽
Mi-Jung Kim
◽
Hye Sook Han
◽
Jin Won Kim
◽
...
2006 ◽
Vol 70
(2)
◽
pp. 106-114
◽
N. Ziras
◽
A. Potamianou
◽
I. Varthalitis
◽
K. Syrigos
◽
S. Tsousis
◽
...
2012 ◽
Vol 9
(1)
◽
pp. 60-65
◽
Amal Halim
◽
Niveen Abotouk
2005 ◽
Vol 20
(6)
◽
pp. 966
◽
Jin Ho Baek
◽
Jong Gwang Kim
◽
Sang Kyun Sohn
◽
Dong Hwan Kim
◽
Kyu Bo Lee
◽
...
2012 ◽
Vol 48
◽
pp. S109-S110
H.K. Chang
◽
Y.C. Lin
◽
K.M. Rau
◽
Y.Y. Chen
◽
K.D. Lee
◽
...
2003 ◽
Vol 35
(4)
◽
pp. 294-298
Yoon Jae Kim
◽
Joo Hyuk Sohn
◽
Chul Kim
◽
Yong Tai Kim
◽
Hai Jin Kim
◽
...
2006 ◽
Vol 103
(2)
◽
pp. 523-526
◽
Paula M. Fracasso
◽
John A. Blessing
◽
Kelly L. Molpus
◽
Lisa M. Adler
◽
Joel I. Sorosky
◽
...